Paul A Price

Title: Paul A Price: Innovator in Monoclonal Antibody Research

Introduction

Paul A Price is a notable inventor based in La Jolla, California. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 10 patents to his name, his work has the potential to impact cancer treatment and other medical applications.

Latest Patents

Among his latest patents is the YKL-40 monoclonal antibody. This invention relates to monoclonal anti-human YKL-antibodies that can modulate biological processes where YKL-40 plays a crucial role. These antibodies are designed to inhibit the growth and induce apoptosis of cells, especially cancer cells. The invention also encompasses pharmaceutical compositions that include these antibodies, which can be used for treating diseases where inhibiting cell growth, differentiation, remodeling of the extracellular matrix, metastasis, and inducing cell death through apoptosis are essential for effective treatment. The antibodies bind to a specific epitope on YKL-40, thereby inhibiting its biological function in these processes.

Career Highlights

Paul A Price has worked with prestigious institutions such as the University of California and Bio-Y A/S. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Some of his notable coworkers include Julia S Johansen and Richard Bonnichsen. Their collaborative efforts have likely enhanced the research and development of innovative solutions in the field of monoclonal antibodies.

Conclusion

Paul A Price is a distinguished inventor whose work in monoclonal antibodies holds promise for advancing cancer treatment and other medical therapies. His contributions to biotechnology continue to influence the field significantly.